The Fifth Expo Medical Device Special Committee Open Innovation Special Online Symposium was successfully held

Author:China International Import Exp Time:2022.07.06

On July 5th, the Fifth China International Import Expo Medical Device Special Committee was successfully held. The event was co -sponsored by the China International Import Expo and the National Convention and Exhibition Center (Shanghai). Liu Fuxue, deputy director of the China International Import Expo Bureau, and Wang Lanming, an audit of the Medical Device Registration Department of the State Drug Administration, delivered a speech. Guo Shuting, deputy director of the Shanghai Drug Administration, and Bidi Medical, Midunli, Siemens Medical, Better Medical, GE Medical, Wanjiang Innovation (Shanghai) Medical Technology Co., Ltd. Company, JLABS Johnson & Johnson Innovation Incubation Platform and other companies and institutions representatives attended the meeting and spoke online.

Liu Fuxue, deputy director of the China International Import Expo Bureau, delivered a speech

Liu Fuxue said that China's medical device field has entered a period of rapid development and has jumped into the world's second largest medical device market. The medical device sector in the medical exhibition area has the characteristics of strong representative, high degree of professionalization, many supporting activities, and strong awareness of innovation. The Import Expo Bureau will actively take pragmatic measures in supporting policies, transaction procurement, service guarantee, etc., and strive to achieve the fifth Expo to support more powerful, better services, and more effective results. The majority of medical device companies and overseas scientific and technological innovation enterprises are welcome to participate in the exhibition to achieve its greater development on the highland of China.

Wang Lanming, Medical Device Registration Division of the State Drug Administration, addressed

Wang Lanming said that the State Drug Administration implemented the Party Central Committee and the State Council's opinions on encouraging the innovation and development of medical equipment, focusing on building a framework for the high -quality development of the medical device industry, and continuously improved the mechanism and measures to encourage the innovation and development of medical device, and effectively fulfill the guarantee guarantee The sacred responsibilities of the safety and effectiveness of medical equipment and the promotion of the healthy development of the industry.

Deng Jianmin, a senior vice president of Bidi Medical Global and General Manager of Greater China, reports on the work plan of the medical device special committee

Deng Jianmin said that the special committee will continue to focus on the two core functions of "innovation incubation" and "open communication", implement various annual work plans, play bridge characters, connect ecological partners, and achieve higher levels of exhibitions and more efficient multi -party dialogue , Resource docking.

Wanjiang Innovation (Shanghai) Medical Technology Co., Ltd. partner Jin Lu spoke

Jin Lu said that the Fifth Expo Medical Exhibition Area Innovation Incubation Zone has completed the roadshow of the exhibition projects twice, and the next stage will continue to carry out exhibitors.

Cheng Xueyi, CEO of Huayi Dachang Commercial (Shanghai) Co., Ltd.

Cheng Xuezheng said that the HKMA Innovation Incubation Zone created a bridge with international innovative medical products for Huayi Dachang and expanded the international perspective of Huayi Dachang.

Zou Shujun, executive president of the National Technology Transfer Eastern Center, speak

Zou Shujun introduced the overall overview of the national technology transfer eastern center, analyzed the implementation plan for overseas SMEs to enter the Chinese market pain point, and shared the center of the center to promote the implementation of the international biopharmaceutical industry.

Chen Xiulun, head of Johnson & Johnson Innovation JLABS Asia Pacific

Chen Xiulun introduced the overseas innovation project incubation experience of Johnson & Johnson's JLABS incubation platform and platform.

Guo Shunting, deputy director of Shanghai Pharmaceutical Supervision Bureau, spoke

Gu Yushao, senior vice president of Metro Global and President of Greater China

Wang Hao, President of Siemens Medical Greater China, spoke

Xu Runhong, President of Best Medical Greater China, spoke

Xu Jun, managing director of GE Medical (China), speak

Swipe left and right to view more

Corporate representatives and competent departments discuss the issues of "medical device innovation model".

The guest of online participating guests

- END -